XSHE
002144
Market cap292mUSD
Oct 09, Last price
11.05CNY
1D
-0.09%
1Q
2.60%
Jan 2017
-51.15%
IPO
-65.78%
Name
Hongda High-Tech Holding Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hongda High-Tech Holding Co.,Ltd. is a Chinese enterprise with a diverse operational scope, active in warp-knitting, healthcare technology (medical devices), commercial trading, and financial investments. Its textile division specializes in manufacturing fabrics for automotive interiors and general apparel. Additionally, the company's medical device segment offers a variety of products designed for numerous organs, including the liver, gallbladder, spleen, kidneys, pancreas, heart, thyroid, breasts, bladder, and uterine adnexa. These automotive interior textiles are exported worldwide, with key markets including the United States, Germany, and Japan. Established in 1985, the firm was initially known as Zhejiang Hongda Warp Knitting Co., Ltd. before officially adopting its current name, Hongda High-Tech Holding Co.,Ltd., in August 2010. Its headquarters are situated in Haining, China.
Key people
Fengjuan Wang
Chief Financial Officer, Director · since 2020
Jianzhou Xu
General Manager, Director · since 2020
Weifeng Gu
Deputy General Manager, Director · since 2016
Xiaohong Jin
Deputy General Manager · since 2023
Yunhao Sun
Deputy General Manager · since 2018
Qiangqiang Ma
Secretary of the Board · since 2020
Zhilin Mao
Vice Chairman of the Board · since 2016
Jun Shen
Vice Chairman of the Board · since 2016
Chairman of the Board · since 2020
Xiangyu Chen
Independent Director · since 2024
Bin Yu
Independent Director · since 2024
Minhua Zhang
Independent Director · since 2024
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||